You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

blastic phase chronic myelogenous leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

Recruiting
  • Recurrent Acute Leukemia
  • +16 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Leukemia Trial in Houston (Dasatinib, Decitabine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 29, 2020

Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase Trial in Ann Arbor (Vorinostat,

Recruiting
  • Hematologic Diseases
  • +11 more
  • Ann Arbor, Michigan
    University of Michigan Health System
Dec 2, 2021

Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

Recruiting
  • Leukemia, Acute Myeloid
  • +7 more
  • Denver, Colorado
  • +4 more
Aug 29, 2022

Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

Withdrawn
  • Drug/Agent Toxicity by Tissue/Organ
  • +3 more
  • amifostine trihydrate
  • +2 more
  • Chicago, Illinois
  • +3 more
Jan 31, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 1, 2022

Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor Trial in United

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • XmAb14045
  • Jacksonville, Florida
  • +8 more
Mar 4, 2022

Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia (CML)
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2020

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +23 more
  • Denver, Colorado
  • +2 more
Jun 17, 2021

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

Completed
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
    • Limerick, Dooradoyle, Ireland
    • +32 more
    Aug 13, 2021

    Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

    Not yet recruiting
    • Chronic Myelogenous Leukemia
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Oct 12, 2023

    Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

    Active, not recruiting
    • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 2, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Leukemia Trial in Canada, United States (troxacitabine)

    Completed
    • Leukemia
    • Duarte, California
    • +19 more
    Jun 7, 2021

    Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Dasatinib Pill
    • Ketoconazole Pill
    • Monterrey, Nuevo Leon, Mexico
      Hospital Universitario Dr. José Eleuterio González
    Nov 25, 2022

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 24, 2022

    Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

    Recruiting
    • Chronic Myeloid Leukemia in Myeloid Blast Crisis
    • +3 more
    • based decitabine and olverembatinib（HQP1351)chemotherapy
    • Guanzhou, China
      Department of Hematology, Nanfang Hospital, Southern Medical Uni
    Dec 6, 2022

    Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

    Not yet recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • APN and medical management
    • +3 more
    • Avignon, Provence-Alpes-Côte d'Azur, France
      Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
    Oct 13, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +4 more
    • Eltrombopag Olamine
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 4, 2022

    Chronic Myelogenous Leukemia Trial in Beijing (TGRX-678)

    Recruiting
    • Chronic Myelogenous Leukemia
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 27, 2022

    Chronic Phase Chronic Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blastic Phase Chronic Myeloid Leukemia Trial

    Completed
    • Chronic Phase Chronic Myeloid Leukemia
    • +4 more
    • Toronto, Ontario, Canada
      Princess Margaret Hospital / University Health Network
    Oct 29, 2020

    Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

    Completed
    • Chronic Myeloid Leukemia
      • East Hanover, New Jersey
        Novartis
      Nov 20, 2023